Search Within

Mark Andrew Dickson

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (25)
Groups
  1. Department of Medicine (58)
  2. GSK Faculty (58)
  3. Human Oncology and Pathogenesis Program (58)
  4. Sarcoma Service (58)
  5. Solid Tumor Oncology Division (58)
  6. Tow Center for Developmental Oncology (TCDO) (57)

More Groups

People
  1. Sandra D'Angelo (55)
  2. Ping Chi (54)
  3. Mary Keohan (53)
  4. Mrinal Gounder (53)
  5. William Tap (53)
  6. Ciara Kelly (42)

More People

Years
  1. 2024 (8)
  2. 2023 (6)
  3. 2022 (13)
  4. 2021 (2)
  5. 2020 (6)
  6. 2019 (8)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Clinical Cancer Research (9)
  3. Annals of Oncology (5)
  4. Nature Communications (3)
  5. JAMA Oncology (2)
  6. The Oncologist (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. American Association for Cancer Research (10)
  3. Oxford University Press (7)
  4. Nature Publishing Group (4)
  5. American Medical Association (2)
  6. Biomed Central Ltd (1)

More Publishers

Results (58)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcome of leiomyosarcomas with somatic alteration in homologous recombination pathway genes
    Journal Article

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Qin, L. X.; Chi, P.; Dickson, M.; Gounder, M.; Kelly, C.; Keohan, M. L.; Nacev, B.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • HLA genotyping in synovial sarcoma: Identifying HLA-A*02 and its association with clinical outcome
    Journal Article

    Rosenbaum, E.; Seier, K.; Bandlamudi, C.; Dickson, M.; Gounder, M.; Keohan, M. L.; Chi, P.; Kelly, C.; Movva, S.; Nacev, B.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Association of immune-related adverse events (irAEs) with improved clinical outcome in sarcoma patients treated with immune checkpoint blockade (ICB)
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Kelly, C. M.; Kiesler, H.; Martindale, M.; Nicholls, C.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B.; Crago, A. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • DNA damage response pathway alterations and clinical outcome in leiomyosarcoma
    Meeting Abstract

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Qin, L. X.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Sequenced circulating tumor (ct) DNA to detect the molecular landscape in advanced GIST
    Meeting Abstract

    Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Wheeler, S.; Hasan, M.; Berger, M. F.; Antonescu, C. R.; Tap, W. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Kelly, C. M.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Qin, L. X.; Adamson, T.; Condy, M. M.; Biniakewitz, M.; Phelan, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma
    Meeting Abstract

    Dickson, M. A.; Koff, A.; D'Angelo, S. P.; Gounder, M. M.; Keohan, M. L.; Kelly, C. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pilot study of NKTR214 and nivolumab in patients with sarcomas
    Meeting Abstract

    D'Angelo, S. P.; Conley, A. P.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Chi, P.; Keohan, M. L.; Livingston, J. A.; Patel, S.; Adamson, T.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save